Filing Details
- Accession Number:
- 0001535264-21-000032
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-11 13:00:00
- Reporting Period:
- 2021-04-08
- Accepted Time:
- 2021-05-11 17:04:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1417926 | Invo Bioscience Inc. | INVO | Surgical & Medical Instruments & Apparatus (3841) | 204036208 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1535264 | Awm Investment Company, Inc. | 527 Madison Avenue Suite 2600 New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-04-08 | 15,000 | $4.08 | 1,067,820 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-09 | 27,811 | $4.08 | 1,095,631 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-12 | 13,146 | $4.00 | 1,108,777 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-13 | 5,800 | $3.97 | 1,114,577 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-14 | 17,152 | $3.95 | 1,131,729 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-15 | 322 | $3.85 | 1,132,051 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-16 | 9,001 | $3.83 | 1,141,052 | No | 4 | P | Indirect | By Limited Partnership |
Common Stock | Acquisiton | 2021-04-19 | 5,801 | $3.64 | 1,146,853 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-20 | 3,500 | $3.90 | 1,150,353 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-04-27 | 3,800 | $4.44 | 1,154,153 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-05-04 | 465 | $3.85 | 1,154,618 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-05-04 | 2,457 | $3.85 | 1,157,075 | No | 4 | P | Indirect | By Limited Partnerships |
Common Stock | Acquisiton | 2021-05-06 | 1,000 | $3.85 | 1,158,075 | No | 4 | P | Indirect | By Limited Partnerships |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnership |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
No | 4 | P | Indirect | By Limited Partnerships |
Footnotes
- This is a weighted average price.
- AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Life Sciences Fund, L.P. (LS). (LS and together with QP and Cay, the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 399,809 shares of Common Stock of the Issuer (the Shares) held by QP, 133,266 Shares held by Cay and 625,000 Shares held by LS.
- Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM.The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall notbe deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of theSecurities Exchange Act of 1934, as amended, or for any other purpose.